Skip to content
lifestyle.ideacrossing.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Diakonos Oncology Corp.
Diakonos Oncology Presents DOC1021 Data Showing Encouraging Survival Signal in Newly Diagnosed Glioblastoma at SNO 2026
November 16, 2026
Diakonos Oncology DOC1021 Clinical Data in Glioblastoma Selected for Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting
November 3, 2026
Diakonos Oncology Announces First Patients Dosed in Phase 1/2 DOC-RM Study of DOC1021 in Refractory Melanoma
July 30, 2026